Original researchPredictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study
References (29)
Predictors of medication adherence in the elderly
Clin Ther.
(1998)- et al.
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
J Chron Dis.
(1987) - et al.
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
J Clin Epidemiol.
(1992) National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2000
(2002)Projections of the Total Resident Population by 5-Year Age Groups, and Sex With Special Age Categories
(2000)Diabetes mellitus
- et al.
Economic costs of diabetes in the U.S. in 2002
Diabetes Care
(2003) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)- et al.
The cost to health plans of poor glycemic control
Diabetes Care
(1997) - et al.
Potential short-term economic benefits of improved glycemic control: A managed care perspective
Diabetes Care
(2001)
Barriers to control of blood glucose in diabetes mellitus
Am J Med Qual.
(2000)
Methodological issues in diabetes research. Measuring adherence
Diabetes Care
(1992)
Compliance with sulfonylureas in a health maintenance organization: A pharmacy record-based study
Ann Pharmacother.
(1999)
Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma
J Am Geriatr Soc.
(2002)
Cited by (292)
Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis
2021, Seminars in Arthritis and RheumatismNon-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review
2021, Journal of Diabetes and its ComplicationsPharmacological treatment of type 2 diabetes in Saudi Arabia: A consensus statement from the Saudi Society of Endocrinology and Metabolism (SSEM)
2021, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsShared decision making, satisfaction with care and medication adherence among patients with diabetes
2020, Patient Education and CounselingCitation Excerpt :Non-adherence has also been associated increased health care utilization and mortality in patients with diabetes [13]. Balkrishnan et al. estimated that a 10% increase in adherence to anti-diabetic medications would reduce cost of health care utilization by 8.6% in patients with diabetes [14]. Greenfield and colleagues reported that shared decision making has potential benefits of improving clinical outcomes, perceived health status and quality of life among patients with diabetes [15].
Patient’s perception of medication and nonadherence to chronic disease treatments. A population-based study in Brazil
2024, Journal of Pharmaceutical Health Services Research
- ∗
Dr. Balkrishnan is currently affiliated with the Division of Management and Policy Sciences, University of Texas School of Public Health, Houston, Texas.
Copyright © 2003 Published by Elsevier Inc.